Clinical Trial Update: Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)

View source ↗

Summary

Update on the post-marketing surveillance protocol for Rekovelle (follitropin delta) pre-filled pen, noting that the PMS study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Rekovelle (follitropin delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility, Female | Status: COMPLETED